Transcending the cutaneous barrier through nanocarrier exploration for passive delivery of anti-hypertensive drugs: a critical review
Common examples of GLP-1 receptor agonists include: Semaglutides(Ozempic and Wegovy) Tirzepatide (Maunjaro and Zepbound) Liraglutide (Victoza and Saxenda) These medications are currently approved for specific medical uses, including: Management of Type 2 diabetes Treatment of certain weight-related medical comorbidities, following clinical guidelines From a physiological perspective, GLP-1 medications support metabolic regulation through several coordinated effects: Increasing insulin secretion in response to food intake Slowing gastric emptying, which prolongs feelings of fullness Reducing glucagon release to help stabilize blood glucose levels Beyond digestion and metabolism, GLP-1 receptors are also found in brain regions involved in reward, motivation, and decision-making
Self-monitoring blood glucose readings (if you perform these) provide additional information about day-to-day glucose patterns and help identify any concerning trends
Klose, M., Huynh, K., Krogsgaard, K., Drejer, J., Byberg, S., Madsbad, S., Magkos, F., Aharaz, A., Edsberg, B., Tfelt, J., & Astrup, A
The antioxidant benefits remain valuable even with reduced sun exposure, pollution and indoor heating create their own oxidative stress